NL8102323A - Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). - Google Patents
Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). Download PDFInfo
- Publication number
- NL8102323A NL8102323A NL8102323A NL8102323A NL8102323A NL 8102323 A NL8102323 A NL 8102323A NL 8102323 A NL8102323 A NL 8102323A NL 8102323 A NL8102323 A NL 8102323A NL 8102323 A NL8102323 A NL 8102323A
- Authority
- NL
- Netherlands
- Prior art keywords
- compound
- formula
- phosphoric acid
- protected
- acid derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 230000000865 phosphorylative effect Effects 0.000 title claims abstract description 12
- -1 HYDROXYL COMPOUNDS Chemical class 0.000 title claims description 26
- 150000003013 phosphoric acid derivatives Chemical class 0.000 title claims description 18
- 230000015572 biosynthetic process Effects 0.000 title description 14
- 238000003786 synthesis reaction Methods 0.000 title description 11
- LLHRMWHYJGLIEV-UHFFFAOYSA-N desoxy Chemical compound COC1=CC(CCN)=CC(OC)=C1C LLHRMWHYJGLIEV-UHFFFAOYSA-N 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 15
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 15
- 239000002157 polynucleotide Substances 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 26
- 239000002777 nucleoside Substances 0.000 claims description 18
- 239000000543 intermediate Substances 0.000 claims description 17
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 10
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 claims description 2
- 150000003335 secondary amines Chemical class 0.000 claims description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims 1
- 229940125797 compound 12 Drugs 0.000 claims 1
- 229940125782 compound 2 Drugs 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 abstract description 8
- 230000026731 phosphorylation Effects 0.000 abstract description 7
- 238000007086 side reaction Methods 0.000 abstract description 4
- 239000013067 intermediate product Substances 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 description 12
- 239000011574 phosphorus Substances 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 102000053602 DNA Human genes 0.000 description 9
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 7
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
- 239000000539 dimer Substances 0.000 description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 125000003158 alcohol group Chemical group 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 125000003835 nucleoside group Chemical group 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- VXVRUFRMQGVZDE-UHFFFAOYSA-N OC(C1=CC=C2N=NN=C2[CH-]1)=O Chemical compound OC(C1=CC=C2N=NN=C2[CH-]1)=O VXVRUFRMQGVZDE-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229940104302 cytosine Drugs 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- YBWTWVJOZHLREZ-JACPFSORSA-N 1-[(2r,4s,5s)-5-[[tert-butyl(dimethyl)silyl]-hydroxymethyl]-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](C(O)[Si](C)(C)C(C)(C)C)[C@@H](O)C1 YBWTWVJOZHLREZ-JACPFSORSA-N 0.000 description 1
- BODVSESPBZOELC-UHFFFAOYSA-N 2-(2-phenylethyl)-1h-imidazole Chemical compound N=1C=CNC=1CCC1=CC=CC=C1 BODVSESPBZOELC-UHFFFAOYSA-N 0.000 description 1
- WILHDXZNJPWBJQ-UHFFFAOYSA-N 8-(1h-imidazol-2-yl)quinoline Chemical compound C1=CNC(C=2C3=NC=CC=C3C=CC=2)=N1 WILHDXZNJPWBJQ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- RQOCLUSOLHPVQX-UHFFFAOYSA-N OP(Cl)([ClH]C1=CC(Cl)=CC=C1)=O Chemical compound OP(Cl)([ClH]C1=CC(Cl)=CC=C1)=O RQOCLUSOLHPVQX-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- KDMWFFHKQUJBLB-UHFFFAOYSA-N n-methyl-1,1-diphenylpropan-2-amine;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C(C)NC)C1=CC=CC=C1 KDMWFFHKQUJBLB-UHFFFAOYSA-N 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 238000005055 short column chromatography Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6518—Five-membered rings
- C07F9/65188—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8102323A NL8102323A (nl) | 1981-05-12 | 1981-05-12 | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). |
CA000402631A CA1202253A (en) | 1981-05-12 | 1982-05-10 | Phosphorylating agent and process for the phosphorylation of organic hydroxyl compounds |
US06/376,510 US4503233A (en) | 1981-05-12 | 1982-05-10 | Phosphorylating agent and process for the phosphorylation of organic hydroxyl compounds |
DE8282200564T DE3263508D1 (en) | 1981-05-12 | 1982-05-10 | Phosphorylating agent and process for the phosphorylation of organic hydroxyl compounds |
AT82200564T ATE13300T1 (de) | 1981-05-12 | 1982-05-10 | Phosphorylierungsmittel und verfahren zur phosphorylierung organischer hydroxylverbindungen. |
EP82200564A EP0064796B1 (de) | 1981-05-12 | 1982-05-10 | Phosphorylierungsmittel und Verfahren zur Phosphorylierung organischer Hydroxylverbindungen |
JP57079833A JPS57203094A (en) | 1981-05-12 | 1982-05-12 | Phosphorylating agent of organic hydroxyl compound and phosphorylation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8102323A NL8102323A (nl) | 1981-05-12 | 1981-05-12 | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). |
NL8102323 | 1981-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8102323A true NL8102323A (nl) | 1982-12-01 |
Family
ID=19837493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8102323A NL8102323A (nl) | 1981-05-12 | 1981-05-12 | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). |
Country Status (7)
Country | Link |
---|---|
US (1) | US4503233A (de) |
EP (1) | EP0064796B1 (de) |
JP (1) | JPS57203094A (de) |
AT (1) | ATE13300T1 (de) |
CA (1) | CA1202253A (de) |
DE (1) | DE3263508D1 (de) |
NL (1) | NL8102323A (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8102323A (nl) * | 1981-05-12 | 1982-12-01 | Unilever Nv | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). |
US4482708A (en) * | 1982-08-09 | 1984-11-13 | Nguyen Nicolas C | 3', 5'-Dinucleoside phosphates of 5,6-dichloro-1-β-D-ribofuranosyl-1-benzimidazole and methods of making and using the same |
USRE34069E (en) * | 1983-08-18 | 1992-09-15 | Biosyntech Gmbh | Process for the preparation of oligonucleotides |
DE3329892A1 (de) * | 1983-08-18 | 1985-03-07 | Köster, Hubert, Prof. Dr., 2000 Hamburg | Verfahren zur herstellung von oligonucleotiden |
US5254691A (en) * | 1990-10-29 | 1993-10-19 | Fuji Photo Film Co., Ltd. | Phosphorylating agent and method for forming phosphodiester bond using the same |
JP2673605B2 (ja) * | 1990-10-29 | 1997-11-05 | 富士写真フイルム株式会社 | リン酸化剤およびそれを用いたホスホジエステル結合形成法 |
EP2551273A4 (de) * | 2010-01-20 | 2013-10-16 | Univ Tokyo | Phosphorylierungs-reagens |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8102323A (nl) * | 1981-05-12 | 1982-12-01 | Unilever Nv | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). |
-
1981
- 1981-05-12 NL NL8102323A patent/NL8102323A/nl not_active Application Discontinuation
-
1982
- 1982-05-10 EP EP82200564A patent/EP0064796B1/de not_active Expired
- 1982-05-10 DE DE8282200564T patent/DE3263508D1/de not_active Expired
- 1982-05-10 US US06/376,510 patent/US4503233A/en not_active Expired - Fee Related
- 1982-05-10 CA CA000402631A patent/CA1202253A/en not_active Expired
- 1982-05-10 AT AT82200564T patent/ATE13300T1/de active
- 1982-05-12 JP JP57079833A patent/JPS57203094A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4503233A (en) | 1985-03-05 |
CA1202253A (en) | 1986-03-25 |
EP0064796B1 (de) | 1985-05-15 |
ATE13300T1 (de) | 1985-06-15 |
EP0064796A3 (en) | 1983-01-05 |
EP0064796A2 (de) | 1982-11-17 |
DE3263508D1 (en) | 1985-06-20 |
JPS57203094A (en) | 1982-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5552538A (en) | Oligonucleotides with cleavable sites | |
US5367066A (en) | Oligonucleotides with selectably cleavable and/or abasic sites | |
EP1795536A1 (de) | Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna | |
US6593088B1 (en) | Reversible photocoupling nucleic acid and phosphoroamidite | |
EP0305201B1 (de) | Geschützte Biotinderivate | |
NL8102323A (nl) | Fosforzuurderivaten, werkwijze ter bereiding daarvan, alsmede werkwijze voor het fosforyleren van organische hydroxylverbindingen en fosfortriesterintermediairen voor gebruik in de synthese van desoxy- en ribo-nucleinezuren (dna en rna). | |
CA2254065A1 (en) | Nucleoside derivatives with photoliable protective groups | |
Grøtli et al. | Solid-phase synthesis of branched RNA and branched DNA/RNA chimeras | |
EP2017282A1 (de) | Verfahren zum capping einer oligonukleinsäure | |
US4419509A (en) | Process for de-cyanoethylating blocked nucleotides | |
US5412088A (en) | 6-O-substituted guanosine derivatives | |
US4426517A (en) | Process for de-cyanoethylating blocked nucleotides | |
CA2554618A1 (en) | Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound | |
US6579976B2 (en) | Process for producing 2′,3′-diethyl substituted nucleoside derivatives | |
US7820810B2 (en) | Process for the synthesis of 2′-O-substituted purine nulceosides | |
Matulic‐Adamic et al. | A Practical Synthesis of 3′‐Thioguanosine and of Its 3′‐Phosphoramidothioite (a Thiophosphoramidite) | |
EP0787740A2 (de) | (6-4)-Photoprodukt-Kupplungseinheit, Verfahren zu deren Herstellung, Verfahren zur Herstellung eines ein (6-4)-Photoprodukt enthaltenden Oligonukleotids, und Verfahren zur Herstellung von DNA, die das (6-4)-Photoprodukt enthält | |
Sekine et al. | Synthesis of oligoribonucleotides by use of 4, 4', 4"-tris (acyloxy) trityl groups for protection of the 6-amino group of adenosine. | |
JPH05320122A (ja) | オリゴヌクレオチドの化学的合成法 | |
Wang et al. | Synthesis of 2′-Substituted Sulfide-Linked Dinucleotides | |
EP0075392A1 (de) | Verfahren zur De-cyanoethylierung von blockierten Nucleotiden | |
JP2000198796A (ja) | 核酸誘導体の製造方法 | |
JPH06345794A (ja) | ヌクレオシド又はヌクレオチド誘導体 | |
Banda et al. | Synthesis of 2-(5-azido-5-deoxy-< img src='/image/spc_char/beta. gif'border= 0>-D-ribofuranosyl)-4-methyl-5-nitro-1, 2, 3-triazole | |
JPH072846A (ja) | テトラヒドロフルフリルアルコール誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1B | A search report has been drawn up | ||
BV | The patent application has lapsed |